Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Luca Bottiglieri"'
Autor:
Lorenzo Gervaso, Davide Ciardiello, Giuliana Gregato, Lorenzo Guidi, Carmine Valenza, Liliana Ascione, Laura Boldrini, Samuele Frassoni, Chiara Alessandra Cella, Francesca Spada, Luigi Funicelli, Giuseppe De Roberto, Wanda Petz, Simona Borin, Marianna Alessandra Gerardi, Luca Bottiglieri, Darina Tamayo, Emilio Bertani, Uberto Fumagalli Romario, Vincenzo Bagnardi, Giuseppe Curigliano, Francesco Bertolini, Nicola Fazio, Maria Giulia Zampino
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: The management of locally advanced rectal cancer (LARC) relies on a multimodal approach. Neither instrumental work-up nor molecular biomarkers are currently available to identify a risk-adapted strategy. Objectives: We aim to investigate
Externí odkaz:
https://doaj.org/article/9f9c536bccb54df2b69506298ebbd4a9
Autor:
Federica Bellerba, Davide Serrano, Johansson Harriet, Chiara Pozzi, Nicola Segata, Amir NabiNejad, Elisa Piperni, Patrizia Gnagnarella, Debora Macis, Valentina Aristarco, Chiara A. Accornero, Paolo Manghi, Aliana Guerrieri Gonzaga, Roberto Biffi, Luca Bottiglieri, Cristina Trovato, Maria Giulia Zampino, Federica Corso, Rino Bellocco, Sara Raimondi, Maria Rescigno, Sara Gandini
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 34, Iss , Pp 100842- (2022)
Background: Several studies suggest a role of gut microbiota in colorectal cancer (CRC) initiation and progression. Vitamin D (vitD) blood levels are also inversely correlated with CRC risk and prognosis. However, these factors’ interplay remains u
Externí odkaz:
https://doaj.org/article/7c5b154d6fb348ef9ba9d2ffa9fded50
Autor:
Arianna Orsini, Luca Mastracci, Isotta Bozzarelli, Anna Ferrari, Federica Isidori, Roberto Fiocca, Marialuisa Lugaresi, Antonietta D’Errico, Deborah Malvi, Erica Cataldi-Stagetti, Paola Spaggiari, Anna Tomezzoli, Luca Albarello, Ari Ristimäki, Luca Bottiglieri, Kausilia K. Krishnadath, Riccardo Rosati, Uberto Fumagalli Romario, Giovanni De Manzoni, Jari Räsänen, Giovanni Martinelli, Sandro Mattioli, Elena Bonora, on behalf of the EACSGE Consortium
Publikováno v:
Cancers, Vol 15, Iss 5, p 1408 (2023)
Esophageal adenocarcinoma (EAC) is a severe malignancy with increasing incidence, poorly understood pathogenesis, and low survival rates. We sequenced 164 EAC samples of naïve patients (without chemo-radiotherapy) with high coverage using next-gener
Externí odkaz:
https://doaj.org/article/c5d63308601143ff8cf0dec7fc752e83
Publikováno v:
Genes, Vol 14, Iss 2, p 376 (2023)
Celiac disease (CD) is a multiorgan autoimmune disorder of the chronic intestinal disease group characterized by duodenal inflammation in genetically predisposed individuals, precipitated by gluten ingestion. The pathogenesis of celiac disease is now
Externí odkaz:
https://doaj.org/article/9acf571b82324589988462a284948171
Autor:
Mariia Ivanova, Konstantinos Venetis, Elena Guerini-Rocco, Luca Bottiglieri, Mauro Giuseppe Mastropasqua, Ornella Garrone, Nicola Fusco, Michele Ghidini
Publikováno v:
Life, Vol 12, Iss 9, p 1403 (2022)
HER2 is an emerging biomarker in colorectal cancer (CRC). This oncogene plays an essential role in regulating cell proliferation, differentiation, migration, and, more in general, tumorigenesis and tumor progression. The most frequent types of HER2 a
Externí odkaz:
https://doaj.org/article/b9afc787e5b64098ba3c616df0adb36c
Autor:
Maria Saveria Rotundo, Maria Giulia Zampino, Paola Simona Ravenda, Vincenzo Bagnardi, Giulia Peveri, Veronica Dell’Acqua, Alessia Surgo, Cristina Trovato, Luca Bottiglieri, Emilio Bertani, Wanda Luisa Petz, Uberto Fumagalli Romario, Nicola Fazio
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background and Aims: The standard treatment of non-metastatic anal squamous cell carcinoma (ASCC) consists of chemotherapy with mitomycin (MMC) plus 5-fluorouracil (5FU) for 1–2 cycles concomitant with pelvic radiotherapy. Subsequent studies introd
Externí odkaz:
https://doaj.org/article/fbd292c6573743aeaee732b10b0e93c3
Autor:
Roberto Fiocca, Luca Mastracci, Marialuisa Lugaresi, Federica Grillo, Antonietta D’Errico, Deborah Malvi, Paola Spaggiari, Anna Tomezzoli, Luca Albarello, Ari Ristimäki, Luca Bottiglieri, Elena Bonora, Kausilia K. Krishnadath, Gian Domenico Raulli, Riccardo Rosati, Uberto Fumagalli Romario, Giovanni De Manzoni, Jari Räsänen, Sandro Mattioli
Publikováno v:
Cancers, Vol 13, Iss 20, p 5211 (2021)
Stage significantly affects survival of esophageal and esophago-gastric junction adenocarcinomas (EA/EGJAs), however, limited evidence for the prognostic role of histologic subtypes is available. The aim of the study was to describe a morphologic app
Externí odkaz:
https://doaj.org/article/26162fc6acd64018a5a19aa3d4953ba4
Autor:
Lorenzo Gervaso, Luca Bottiglieri, Monica Isabel Meneses-Medina, Stefania Pellicori, Roberto Biffi, Uberto Fumagalli Romario, Stefano De Pascale, Isabella Sala, Vincenzo Bagnardi, Massimo Barberis, Chiara Alessandra Cella, Nicola Fazio
Purpose: Neoadjuvant chemotherapy (NAC) significantly improved the prognosis of patients with locally advanced gastric cancer (LAGC). Several biomarkers, including HER2 and MMR/MSI are crucial for treatment decisions in the advanced stage but, curren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da52a663461d7f525b33bb37b74429fd
https://hdl.handle.net/10281/416030
https://hdl.handle.net/10281/416030
Autor:
Roberto Fiocca, Luca Mastracci, Marialuisa Lugaresi, Federica Grillo, Antonietta D'Errico, Deborah Malvi, Paola Spaggiari, Anna Tomezzoli, Luca Albarello, Ari Ristimäki, Luca Bottiglieri, Elena Bonora, Kausilia K Krishnadath, Riccardo Rosati, Uberto Fumagalli Romario, Giovanni De Manzoni, Jari Räsänen, Sandro Mattioli
Publikováno v:
Diseases of the Esophagus. 35
In a previous study on esophageal adenocarcinoma (EAC) cases submitted to surgery (without neoadjuvant treatment), an algorithm (EACGSE classification) 1 based on morphologic distinctions provided significant prognostic impact. Tumor budding is a spe
Autor:
Elena Bonora, Luca Mastracci, Arianna Orsini, Isotta Bozzarelli, Federica Isidori, Valentina Tassi, Roberto Fiocca, Marialuisa Lugaresi, Antonietta D'Errico, Deborah Malvi, Paola Spaggiari, Anna Tomezzoli, Luca Albarello, Ari Ristimäki, Luca Bottiglieri, Kausilia Krishnadath, Riccardo Rosati, Uberto Fumagalli Romario, Giovanni De Manzoni, Jari Räsänen, Sandro Mattioli
Publikováno v:
Diseases of the Esophagus. 35
The incidence of esophageal adenocarcinoma (EAC) has constantly risen in western countries over the past decades, often diagnosed at advanced stage and with a five-year survival around 20%1. In a previous study on EAC cases submitted to surgery (with